Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Indian Journal of Human Genetics|June 25, 2014
Unexpected Inheritance of a Balanced Homologous translocation t(22q;22q) from father to a phenotypically normal daughterD K Chopade, Harish Harde, Pallavi Ugale, et al.Nature Communications|June 21, 2024
Comparing the effects of CETP in East Asian and European ancestries: a Mendelian randomization studyDiana Dunca, Sandesh Chopade, María Gordillo-Marañón, et al.Open Biology|July 16, 2024
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disordersA Floriaan Schmidt, Chris Finan, Sandesh Chopade, et al.Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disordersA Floriaan Schmidt, Chris Finan, Sandesh Chopade, et al.Science Advances|May 20, 2026
The immunoproteome and multimorbidity: A Mendelian randomization studyNikita Hukerikar, Aroon D Hingorani, Sandesh Chopade, et al.Genome Medicine|October 21, 2024
Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillationMarion van Vugt, Chris Finan, Sandesh Chopade, et al.Neurology|September 1, 2023
Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization StudyMona M Almramhi, Chris Finan, Catherine S Storm, et al.Translational Psychiatry|June 2, 2026
An integrative mendelian randomisation and drug mechanism framework for target prioritisation and therapeutic repurposing in major depressionAbigail R Ter Kuile, Chris Finan, Sandesh Chopade, et al.Nature Communications|June 28, 2020
Genetic drug target validation using Mendelian randomisationAmand F Schmidt, Chris Finan, Maria Gordillo-Marañón, et al.Scientific Reports|December 13, 2019
Improving the odds of drug development success through human genomics: modelling studyAroon D Hingorani, Valerie Kuan, Chris Finan, et al.Pageof 2